Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295154811> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- W4295154811 endingPage "207" @default.
- W4295154811 startingPage "199" @default.
- W4295154811 abstract "Objective: The aim of this study was to develop the oral Venlafaxine HCl controlled-release organogel (organogel–CR) by using one-factor response surface methodology (RSM). Methods: In this study, Drug-excipient compatibility was evaluated by FT-IR. A total of 14 experimental runs were carried out employing the detailed conditions designed by a single factor completely randomized design based on the response surface methodology was used to check the concentration effect of 12-Hydroxy stearic acid (12-HSA) at different cooling rates on drug release at 10 h (Q10) and after 12 h (Q12). Multiple linear regression analysis, analysis of variance (ANOVA) and graphical representation of the influence factor were performed by using design expert 12. The developed organogel was also evaluated for viscosity, strength, transition temperature, diffusivity and Scanning electron microscopy (SEM). Prepared organogel was filled in the capsule and investigated for weight variation, drug content, erosion of organogel and In vitro drug release study. Results: FT-IR results showed that there was no chemical interaction between the drug and excipients. The SEM photograph indicates that the developed organogel was highly viscous with 3D network structure. The experimental confirmation tests showed a correlation between the predicted and experimental responses (R2 = 0.9937 and 0.9709). The results of ANOVA suggested that calculated F values of all dependent variables are greater than tabulated values. The optimal point obtained was located in the valid region and the optimum in vitro release of the predicted batch containing 7.9% concentration of 12-HSA with gradual cooling rate. To validate the evolved mathematical models, a checkpoint was selected and its desirability value was found to be 0.866. Conclusion: Oral controlled release Venlafaxine HCl organogel fix the problem of repeated dosing and patient noncompliance." @default.
- W4295154811 created "2022-09-11" @default.
- W4295154811 creator A5045223518 @default.
- W4295154811 creator A5048968009 @default.
- W4295154811 creator A5060632428 @default.
- W4295154811 date "2022-09-07" @default.
- W4295154811 modified "2023-10-14" @default.
- W4295154811 title "ONE FACTOR RESPONSE SURFACE METHODOLOGY (RSM) FOR THE OPTIMIZATION OF ORAL VENLAFAXINE HCL CONTROLLED RELEASE ORGANOGEL" @default.
- W4295154811 doi "https://doi.org/10.22159/ijap.2022v14i5.45517" @default.
- W4295154811 hasPublicationYear "2022" @default.
- W4295154811 type Work @default.
- W4295154811 citedByCount "0" @default.
- W4295154811 crossrefType "journal-article" @default.
- W4295154811 hasAuthorship W4295154811A5045223518 @default.
- W4295154811 hasAuthorship W4295154811A5048968009 @default.
- W4295154811 hasAuthorship W4295154811A5060632428 @default.
- W4295154811 hasBestOaLocation W42951548111 @default.
- W4295154811 hasConcept C105795698 @default.
- W4295154811 hasConcept C113196181 @default.
- W4295154811 hasConcept C150077022 @default.
- W4295154811 hasConcept C169222746 @default.
- W4295154811 hasConcept C185592680 @default.
- W4295154811 hasConcept C192562407 @default.
- W4295154811 hasConcept C2776369308 @default.
- W4295154811 hasConcept C33923547 @default.
- W4295154811 hasConcept C43617362 @default.
- W4295154811 hasConceptScore W4295154811C105795698 @default.
- W4295154811 hasConceptScore W4295154811C113196181 @default.
- W4295154811 hasConceptScore W4295154811C150077022 @default.
- W4295154811 hasConceptScore W4295154811C169222746 @default.
- W4295154811 hasConceptScore W4295154811C185592680 @default.
- W4295154811 hasConceptScore W4295154811C192562407 @default.
- W4295154811 hasConceptScore W4295154811C2776369308 @default.
- W4295154811 hasConceptScore W4295154811C33923547 @default.
- W4295154811 hasConceptScore W4295154811C43617362 @default.
- W4295154811 hasLocation W42951548111 @default.
- W4295154811 hasOpenAccess W4295154811 @default.
- W4295154811 hasPrimaryLocation W42951548111 @default.
- W4295154811 hasRelatedWork W130093311 @default.
- W4295154811 hasRelatedWork W1995648723 @default.
- W4295154811 hasRelatedWork W2146158298 @default.
- W4295154811 hasRelatedWork W2165622072 @default.
- W4295154811 hasRelatedWork W2246325624 @default.
- W4295154811 hasRelatedWork W2354247634 @default.
- W4295154811 hasRelatedWork W2588589272 @default.
- W4295154811 hasRelatedWork W4206731776 @default.
- W4295154811 hasRelatedWork W4235421818 @default.
- W4295154811 hasRelatedWork W73990069 @default.
- W4295154811 isParatext "false" @default.
- W4295154811 isRetracted "false" @default.
- W4295154811 workType "article" @default.